ES2124411T3 - 1-arilcicloalquil-sulfuros, -sulfoxidos y -sulfonas para el tratamiento de depresion, ansiedad y enfermedad de parkinson. - Google Patents
1-arilcicloalquil-sulfuros, -sulfoxidos y -sulfonas para el tratamiento de depresion, ansiedad y enfermedad de parkinson.Info
- Publication number
- ES2124411T3 ES2124411T3 ES94916944T ES94916944T ES2124411T3 ES 2124411 T3 ES2124411 T3 ES 2124411T3 ES 94916944 T ES94916944 T ES 94916944T ES 94916944 T ES94916944 T ES 94916944T ES 2124411 T3 ES2124411 T3 ES 2124411T3
- Authority
- ES
- Spain
- Prior art keywords
- sub
- anxiety
- parkinson
- depression
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939309749A GB9309749D0 (en) | 1993-05-12 | 1993-05-12 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2124411T3 true ES2124411T3 (es) | 1999-02-01 |
Family
ID=10735317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94916944T Expired - Lifetime ES2124411T3 (es) | 1993-05-12 | 1994-05-07 | 1-arilcicloalquil-sulfuros, -sulfoxidos y -sulfonas para el tratamiento de depresion, ansiedad y enfermedad de parkinson. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5652271A (enExample) |
| EP (1) | EP0715620B1 (enExample) |
| JP (2) | JP3606326B2 (enExample) |
| KR (1) | KR100295264B1 (enExample) |
| AT (1) | ATE172719T1 (enExample) |
| AU (1) | AU681669B2 (enExample) |
| BG (1) | BG61913B1 (enExample) |
| BR (2) | BR9406577A (enExample) |
| CZ (1) | CZ290711B6 (enExample) |
| DE (1) | DE69414264T2 (enExample) |
| DK (1) | DK0715620T3 (enExample) |
| ES (1) | ES2124411T3 (enExample) |
| FI (1) | FI955429A7 (enExample) |
| GB (1) | GB9309749D0 (enExample) |
| HU (1) | HU211124A9 (enExample) |
| IL (1) | IL109635A (enExample) |
| LV (1) | LV11320A (enExample) |
| MY (1) | MY110773A (enExample) |
| NO (1) | NO305165B1 (enExample) |
| NZ (1) | NZ266776A (enExample) |
| PH (1) | PH30418A (enExample) |
| PL (1) | PL176400B1 (enExample) |
| RO (1) | RO115519B1 (enExample) |
| RU (1) | RU2135467C1 (enExample) |
| SK (1) | SK281257B6 (enExample) |
| TW (1) | TW318833B (enExample) |
| UA (1) | UA42722C2 (enExample) |
| WO (1) | WO1994026704A1 (enExample) |
| ZA (1) | ZA943241B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19518988A1 (de) * | 1995-05-29 | 1996-12-05 | Basf Ag | Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit |
| GB9524681D0 (en) | 1995-12-02 | 1996-01-31 | Knoll Ag | Chemical process |
| GB9915617D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| US7094427B2 (en) * | 2002-05-29 | 2006-08-22 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
| US20030224045A1 (en) * | 2002-05-29 | 2003-12-04 | Chien-Hsuan Han | Combination immediate release sustained release levodopa/carbidopa dosage forms |
| US20040166159A1 (en) * | 2002-05-29 | 2004-08-26 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa |
| US20060013875A1 (en) * | 2002-05-29 | 2006-01-19 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
| PT2011796E (pt) * | 2006-04-26 | 2014-11-26 | Toyama Chemical Co Ltd | Indutor de neurogénese ou agente terapêutico utilizado em neuropatias que compreende um derivado de um éter alquílico ou um seu sal |
| PL3054929T3 (pl) | 2013-10-07 | 2021-05-31 | Impax Laboratories, Llc | Mukoadhezyjne preparaty lewodopy i / lub estrów lewodopy o kontrolowanym uwalnianiu oraz ich zastosowania |
| US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
| KR20230124622A (ko) | 2020-12-22 | 2023-08-25 | 암닐 파마슈티컬스 엘엘씨 | 레보도파 투여 요법 |
| US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52768B1 (en) * | 1981-04-06 | 1988-02-17 | Boots Co Ltd | 1-arylcyclobutylalkylamine compounds useful as therapeutic agents |
| IE56000B1 (en) * | 1982-09-30 | 1991-03-13 | Boots Co Plc | 1-arylcyclobutylalkylamine compounds |
| IE56001B1 (en) * | 1982-09-30 | 1991-03-13 | Boots Co Plc | 1-arylcyclobutylmethylamine compounds |
| GB8501192D0 (en) * | 1985-01-17 | 1985-02-20 | Boots Co Plc | Therapeutic agents |
| CH664957A5 (de) * | 1985-09-24 | 1988-04-15 | Lonza Ag | Verfahren zur herstellung von 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamid. |
| GB8704777D0 (en) * | 1987-02-28 | 1987-04-01 | Boots Co Plc | Medical treatment |
-
1993
- 1993-05-12 GB GB939309749A patent/GB9309749D0/en active Pending
-
1994
- 1994-05-07 ES ES94916944T patent/ES2124411T3/es not_active Expired - Lifetime
- 1994-05-07 BR BR9406577A patent/BR9406577A/pt not_active Application Discontinuation
- 1994-05-07 RO RO95-01958A patent/RO115519B1/ro unknown
- 1994-05-07 AU AU68433/94A patent/AU681669B2/en not_active Expired
- 1994-05-07 AT AT94916944T patent/ATE172719T1/de active
- 1994-05-07 WO PCT/EP1994/001494 patent/WO1994026704A1/en not_active Ceased
- 1994-05-07 FI FI955429A patent/FI955429A7/fi unknown
- 1994-05-07 US US08/545,752 patent/US5652271A/en not_active Expired - Lifetime
- 1994-05-07 KR KR1019950705037A patent/KR100295264B1/ko not_active Expired - Lifetime
- 1994-05-07 PL PL94311628A patent/PL176400B1/pl unknown
- 1994-05-07 EP EP94916944A patent/EP0715620B1/en not_active Expired - Lifetime
- 1994-05-07 DE DE69414264T patent/DE69414264T2/de not_active Expired - Lifetime
- 1994-05-07 DK DK94916944T patent/DK0715620T3/da active
- 1994-05-07 NZ NZ266776A patent/NZ266776A/en not_active IP Right Cessation
- 1994-05-07 JP JP52494694A patent/JP3606326B2/ja not_active Expired - Lifetime
- 1994-05-07 SK SK1407-95A patent/SK281257B6/sk not_active IP Right Cessation
- 1994-05-07 CZ CZ19952936A patent/CZ290711B6/cs not_active IP Right Cessation
- 1994-05-07 UA UA95114926A patent/UA42722C2/uk unknown
- 1994-05-07 RU RU95122740A patent/RU2135467C1/ru active
- 1994-05-11 ZA ZA943241A patent/ZA943241B/xx unknown
- 1994-05-12 PH PH48262A patent/PH30418A/en unknown
- 1994-05-12 IL IL109635A patent/IL109635A/en not_active IP Right Cessation
- 1994-05-12 MY MYPI94001186A patent/MY110773A/en unknown
- 1994-11-11 TW TW083110470A patent/TW318833B/zh active
-
1995
- 1995-06-30 HU HU95P/P00686P patent/HU211124A9/hu unknown
- 1995-11-10 NO NO954542A patent/NO305165B1/no not_active IP Right Cessation
- 1995-11-10 BG BG100127A patent/BG61913B1/bg unknown
- 1995-12-11 LV LV950366A patent/LV11320A/xx unknown
-
1997
- 1997-04-22 BR BR1100306-5A patent/BR1100306A/pt active IP Right Grant
-
2004
- 2004-06-16 JP JP2004178477A patent/JP2004331669A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9106819A (pt) | Polimeros contendo unidades diester,processo para a preparacao de um polimero e compostos | |
| NO960380L (no) | Middel til behandling av neurosykdommer | |
| ES2113081T3 (es) | 1,4-benzotiazepinas utiles como agentes neurologicos. | |
| CO4920242A1 (es) | Compuestos inhibidores de metalopreoteasas 1,4-heterocicli- cos, composiciones farmaceuticas que los contienen y metodos para su utilizacion | |
| NZ506793A (en) | Conformationally constrained amino acid compounds and their use for treating epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders | |
| ES2150663T3 (es) | Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina. | |
| UY27952A1 (es) | Nuevos derivados de benzoimidazol útiles como agentes antiproliferativos | |
| BR9803472A (pt) | Processo para inibir a polimerização de um composto vinil aromático durante a destilação do composto vinil aromático. | |
| ATE261435T1 (de) | Benzofuranderivate, verfahren zu ihrer herstellung und deren verwendungen | |
| MX9303124A (es) | Compuestos organicos de benzodiazepina, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen. | |
| CO5050366A1 (es) | Compuesto fungicida correspondiente a compuesto 7-bromo-3- metil-3,4-dihidrotienol[3,2-d]pirimidin-4-ona | |
| MX9307332A (es) | 3-(aminoalquilamino)-1,2-bencisoxasoles substituidos y compuestos relacionados. | |
| ES2101449T3 (es) | Inhibicion de la seborrea y el acne. | |
| MX9301240A (es) | Derivados heterociclicos de cetona, condensados, metodo para su produccion y composicion farmaceutica que los contiene. | |
| AR046874A1 (es) | Nuevos metodos | |
| PT1512679E (pt) | Novos derivados de adamantano com actividades neuroprotectoras, anti-depressivas e anti-isquémicas e processo para os preparar | |
| BR9406577A (pt) | Compostos uso dos mesmos processo para a preparação dos mesmos e processo para neuroproteção ou para tratamento da depressão ansiedade doença de parkinson obesidade distúrbios cognitivos ataques e distúrbios neurológicos | |
| CO5080731A1 (es) | Compuestos de tetrahidroisoquinolinil-carboxamida y composiciones que los contienen | |
| DK0707570T3 (da) | Isoquinolinderivater som terapeutiske midler | |
| ES2108474T3 (es) | Aminas heterociclicas que tienen actividad sobre el sistema nervioso central. | |
| ES2180100T3 (es) | Agentes antitumorales de tioxantenona. | |
| PL312471A1 (en) | Benzene derivatives effective in ischaemia diseases | |
| BR9408387A (pt) | Processo para estabilização das e misturas estabilizadoras para mistura de poliolefina contendo pvdc | |
| ES2066232T3 (es) | Derivados de los acidos glutamico y aspartico con actividad antigastrina y un metodo para su preparacion. | |
| ES2190610T3 (es) | Sintesis de 3-carbometoxi-4,5-dimetiltiofeno. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 715620 Country of ref document: ES |